person · Reporting owner
Thomas H. Lee Equity Fund VII, L.P.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Syneos Health, Inc.SYNH · Entity 109360 | Director | June 07, 2021 | June 09, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Syneos Health, Inc.
Report date June 07, 2021 · Filed June 09, 2021
Jointly reported with THOMAS H. LEE ADVISORS, LLC, Thomas H. Lee Equity Fund VI (2019), L.P., THOMAS H LEE PARTNERS LP, THL Fund VI (2019) Coinvestment Partners, L.P., Thomas H. Lee Parallel Fund VII, L.P., Thomas H. Lee Parallel (Cayman) Fund VII, L.P., THL Managers VI, LLC, THL Managers VII, LLC, THL HOLDCO, LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 391,991 |
Reported balance
After 2021-06-07 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2021-06-07 · Sale · Disposed 4,816,880 · Balance 391,991 F4: See Exhibit 99.1 for text of footnote (4). F5: See Exhibit 99.1 for text of footnote (5). F1: See Exhibit 99.1 for text of footnote (1). F2: See Exhibit 99.1 for text of footnote (2). F3: See Exhibit 99.1 for text of footnote (3). |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2021-06-07 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2021-06-07 · Sale · Disposed 226,128 · Balance 0 F6: See Exhibit 99.1 for text of footnote (6). F7: See Exhibit 99.1 for text of footnote (7). F1: See Exhibit 99.1 for text of footnote (1). F2: See Exhibit 99.1 for text of footnote (2). F3: See Exhibit 99.1 for text of footnote (3). |
| Class A Common StockSEC Table I · non-derivative | Direct | 37 |
Reported balance
After 2021-06-07 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2021-06-07 · Sale · Disposed 815 · Balance 37 F8: See Exhibit 99.1 for text of footnote (8). F10: See Exhibit 99.1 for text of footnote (10). |
| Class A Common StockSEC Table I · non-derivative | Direct | 14 |
Reported balance
After 2021-06-07 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2021-06-07 · Sale · Disposed 313 · Balance 14 F9: See Exhibit 99.1 for text of footnote (9). F11: See Exhibit 99.1 for text of footnote (11). |
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-06-07 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2021-06-07 · Sale · Disposed 37 · Balance 0 F12: See Exhibit 99.1 for text of footnote (12). F14: See Exhibit 99.1 for text of footnote (14). |
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-06-07 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2021-06-07 · Sale · Disposed 14 · Balance 0 F13: See Exhibit 99.1 for text of footnote (13). F15: See Exhibit 99.1 for text of footnote (15). |
Filing footnotes · ownership attribution and instrument terms
F1: See Exhibit 99.1 for text of footnote (1).
F2: See Exhibit 99.1 for text of footnote (2).
F3: See Exhibit 99.1 for text of footnote (3).
F4: See Exhibit 99.1 for text of footnote (4).
F5: See Exhibit 99.1 for text of footnote (5).
F6: See Exhibit 99.1 for text of footnote (6).
F7: See Exhibit 99.1 for text of footnote (7).
F8: See Exhibit 99.1 for text of footnote (8).
F9: See Exhibit 99.1 for text of footnote (9).
F10: See Exhibit 99.1 for text of footnote (10).
F11: See Exhibit 99.1 for text of footnote (11).
F12: See Exhibit 99.1 for text of footnote (12).
F13: See Exhibit 99.1 for text of footnote (13).
F14: See Exhibit 99.1 for text of footnote (14).
F15: See Exhibit 99.1 for text of footnote (15).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2021 Filed Jun 9, 2021 17:17 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 14 | $81.20 | $1,136.80 |
DisclosureSEC source: 0001140361-21-020386 · form4.xml · nonDerivative · entry 6 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F13 · shares: See Exhibit 99.1 for text of footnote (13). F15 · balance_after: See Exhibit 99.1 for text of footnote (15). Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 17:17 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 37 | $81.20 | $3,004.40 |
DisclosureSEC source: 0001140361-21-020386 · form4.xml · nonDerivative · entry 5 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F12 · shares: See Exhibit 99.1 for text of footnote (12). F14 · balance_after: See Exhibit 99.1 for text of footnote (14). Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 17:17 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 313 | $81.20 | $25,415.60 |
DisclosureSEC source: 0001140361-21-020386 · form4.xml · nonDerivative · entry 4 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14 F9 · shares: See Exhibit 99.1 for text of footnote (9). F11 · balance_after: See Exhibit 99.1 for text of footnote (11). Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 17:17 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 815 | $81.20 | $66,178.00 |
DisclosureSEC source: 0001140361-21-020386 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37 F8 · shares: See Exhibit 99.1 for text of footnote (8). F10 · balance_after: See Exhibit 99.1 for text of footnote (10). Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 17:17 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 226,128 | $81.20 | $18,361,593.60 |
DisclosureSEC source: 0001140361-21-020386 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F6 · shares: See Exhibit 99.1 for text of footnote (6). F7 · balance_after: See Exhibit 99.1 for text of footnote (7). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 17:17 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 4,816,880 | $81.20 | $391,130,656.00 |
DisclosureSEC source: 0001140361-21-020386 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 391,991 F4 · shares: See Exhibit 99.1 for text of footnote (4). F5 · balance_after: See Exhibit 99.1 for text of footnote (5). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document |
| May 12, 2021 Filed May 14, 2021 21:55 UTC | Syneos Health, Inc. SYNH · Entity 109360 | GrantClass A Common Stock | 2,364 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017529 · form4.xml · nonDerivative · entry 5 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,392 F7 · shares: See Exhibit 99.1 for text of footnote (7). F7 · price: See Exhibit 99.1 for text of footnote (7). F9 · price: See Exhibit 99.1 for text of footnote (9). Read SEC document |
| May 12, 2021 Filed May 14, 2021 21:55 UTC | Syneos Health, Inc. SYNH · Entity 109360 | GrantClass A Common Stock | 2,364 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017529 · form4.xml · nonDerivative · entry 4 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,392 F7 · shares: See Exhibit 99.1 for text of footnote (7). F7 · price: See Exhibit 99.1 for text of footnote (7). F8 · price: See Exhibit 99.1 for text of footnote (8). Read SEC document |
| May 12, 2021 Filed May 18, 2021 21:49 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 25 | $81.04 | $2,026.00 |
DisclosureSEC source: 0001140361-21-017952 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327 F8 · shares: See Exhibit 99.1 for text of footnote (8). F4 · price: See Exhibit 99.1 for text of footnote (4). F10 · balance_after: See Exhibit 99.1 for text of footnote (10). Read SEC document |
| May 12, 2021 Filed May 18, 2021 21:49 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 64 | $81.04 | $5,186.56 |
DisclosureSEC source: 0001140361-21-017952 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 852 F7 · shares: See Exhibit 99.1 for text of footnote (7). F4 · price: See Exhibit 99.1 for text of footnote (4). F9 · balance_after: See Exhibit 99.1 for text of footnote (9). Read SEC document |
| May 12, 2021 Filed May 18, 2021 21:49 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 379,789 | $81.04 | $30,778,100.56 |
DisclosureSEC source: 0001140361-21-017952 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,208,835 F5 · shares: See Exhibit 99.1 for text of footnote (5). F4 · price: See Exhibit 99.1 for text of footnote (4). F6 · balance_after: See Exhibit 99.1 for text of footnote (6). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document |
| May 12, 2021 Filed May 20, 2021 21:45 UTC Amendment | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 25 | $81.04 | $2,026.00 |
DisclosureSEC source: 0001140361-21-018265 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327 F8 · shares: See Exhibit 99.1 for text of footnote (8). F4 · price: See Exhibit 99.1 for text of footnote (4). F10 · balance_after: See Exhibit 99.1 for text of footnote (10). Read SEC document |
| May 12, 2021 Filed May 20, 2021 21:45 UTC Amendment | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 64 | $81.04 | $5,186.56 |
DisclosureSEC source: 0001140361-21-018265 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 852 F7 · shares: See Exhibit 99.1 for text of footnote (7). F4 · price: See Exhibit 99.1 for text of footnote (4). F9 · balance_after: See Exhibit 99.1 for text of footnote (9). Read SEC document |
| May 12, 2021 Filed May 20, 2021 21:45 UTC Amendment | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 379,789 | $81.04 | $30,778,100.56 |
DisclosureSEC source: 0001140361-21-018265 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,208,871 F5 · shares: See Exhibit 99.1 for text of footnote (5). F4 · price: See Exhibit 99.1 for text of footnote (4). F6 · balance_after: See Exhibit 99.1 for text of footnote (6). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:27 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 12 | $81.04 | $972.48 |
DisclosureSEC source: 0001140361-21-016730 · form4.xml · nonDerivative · entry 6 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352 F13 · shares: See Exhibit 99.1 for text of footnote F15 · balance_after: See Exhibit 99.1 for text of footnote Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:27 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 30 | $81.04 | $2,431.20 |
DisclosureSEC source: 0001140361-21-016730 · form4.xml · nonDerivative · entry 5 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 916 F12 · shares: See Exhibit 99.1 for text of footnote F14 · balance_after: See Exhibit 99.1 for text of footnote Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:27 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 208 | $81.04 | $16,856.32 |
DisclosureSEC source: 0001140361-21-016730 · form4.xml · nonDerivative · entry 4 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364 F9 · shares: See Exhibit 99.1 for text of footnote F11 · balance_after: See Exhibit 99.1 for text of footnote Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:27 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 544 | $81.04 | $44,085.76 |
DisclosureSEC source: 0001140361-21-016730 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 946 F8 · shares: See Exhibit 99.1 for text of footnote F10 · balance_after: See Exhibit 99.1 for text of footnote Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:27 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 183,292 | $81.04 | $14,853,983.68 |
DisclosureSEC source: 0001140361-21-016730 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,601,430 F6 · shares: See Exhibit 99.1 for text of footnote F7 · balance_after: See Exhibit 99.1 for text of footnote F1 · ownership.nature: See Exhibit 99.1 for text of footnote F2 · ownership.nature: See Exhibit 99.1 for text of footnote F3 · ownership.nature: See Exhibit 99.1 for text of footnote Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:27 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 3,207,596 | $81.04 | $259,943,579.84 |
DisclosureSEC source: 0001140361-21-016730 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director THL Managers VI, LLC · CIK 0001604098 · Director THL Managers VII, LLC · CIK 0001753032 · Director THL HOLDCO, LLC · CIK 0001757181 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,899,055 F4 · shares: See Exhibit 99.1 for text of footnote F5 · balance_after: See Exhibit 99.1 for text of footnote F1 · ownership.nature: See Exhibit 99.1 for text of footnote F2 · ownership.nature: See Exhibit 99.1 for text of footnote F3 · ownership.nature: See Exhibit 99.1 for text of footnote Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 17:00 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 17 | $74.18 | $1,260.98 |
DisclosureSEC source: 0001140361-21-007501 · form4.xml · nonDerivative · entry 6 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 572 F13 · shares: See Exhibit 99.1 for text of footnote (13). F15 · balance_after: See Exhibit 99.1 for text of footnote (15). Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 17:00 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 45 | $74.18 | $3,337.88 |
DisclosureSEC source: 0001140361-21-007501 · form4.xml · nonDerivative · entry 5 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,490 F12 · shares: See Exhibit 99.1 for text of footnote (12). F14 · balance_after: See Exhibit 99.1 for text of footnote (14). Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 17:00 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 242 | $74.18 | $17,950.35 |
DisclosureSEC source: 0001140361-21-007501 · form4.xml · nonDerivative · entry 4 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 589 F9 · shares: See Exhibit 99.1 for text of footnote (9). F11 · balance_after: See Exhibit 99.1 for text of footnote (11). Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 17:00 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 631 | $74.18 | $46,804.43 |
DisclosureSEC source: 0001140361-21-007501 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,535 F8 · shares: See Exhibit 99.1 for text of footnote (8). F10 · balance_after: See Exhibit 99.1 for text of footnote (10). Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 17:00 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 277,114 | $74.18 | $20,554,930.95 |
DisclosureSEC source: 0001140361-21-007501 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 9,106,651 F6 · shares: See Exhibit 99.1 for text of footnote (6). F7 · balance_after: See Exhibit 99.1 for text of footnote (7). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 17:00 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 3,717,905 | $74.18 | $275,775,603.38 |
DisclosureSEC source: 0001140361-21-007501 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 9,517,640 F4 · shares: See Exhibit 99.1 for text of footnote (4). F5 · balance_after: See Exhibit 99.1 for text of footnote (5). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 17:05 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 174 | $61.28 | $10,662.72 |
DisclosureSEC source: 0001140361-20-027518 · form4.xml · nonDerivative · entry 5 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 831 F9 · shares: See Exhibit 99.1 for text of footnote (9). F11 · balance_after: See Exhibit 99.1 for text of footnote (11). Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 17:05 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 453 | $61.28 | $27,759.84 |
DisclosureSEC source: 0001140361-20-027518 · form4.xml · nonDerivative · entry 4 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,166 F8 · shares: See Exhibit 99.1 for text of footnote (8). F10 · balance_after: See Exhibit 99.1 for text of footnote (10). Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 17:05 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 2,771,132 | $61.28 | $169,814,968.96 |
DisclosureSEC source: 0001140361-20-027518 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 13,235,545 F4 · shares: See Exhibit 99.1 for text of footnote (4). F5 · balance_after: See Exhibit 99.1 for text of footnote (5). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 17:30 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 203 | $59.26 | $12,029.78 |
DisclosureSEC source: 0001140361-20-021021 · form4.xml · nonDerivative · entry 5 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,005 F9 · shares: See Exhibit 99.1 for text of footnote (9). F11 · balance_after: See Exhibit 99.1 for text of footnote (11). Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 17:30 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 529 | $59.26 | $31,348.54 |
DisclosureSEC source: 0001140361-20-021021 · form4.xml · nonDerivative · entry 4 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,619 F8 · shares: See Exhibit 99.1 for text of footnote (8). F10 · balance_after: See Exhibit 99.1 for text of footnote (10). Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 17:30 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 3,232,987 | $59.26 | $191,586,809.62 |
DisclosureSEC source: 0001140361-20-021021 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 16,006,677 F4 · shares: See Exhibit 99.1 for text of footnote (4). F5 · balance_after: See Exhibit 99.1 for text of footnote (5). F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). Read SEC document |
| May 27, 2020 Filed May 29, 2020 20:37 UTC | Syneos Health, Inc. SYNH · Entity 109360 | GrantClass A Common Stock | 2,803 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-20-012777 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,028 F5 · shares: See Exhibit 99.1 for text of footnote (5). F5 · price: See Exhibit 99.1 for text of footnote (5). F7 · price: See Exhibit 99.1 for text of footnote (7). Read SEC document |
| May 27, 2020 Filed May 29, 2020 20:37 UTC | Syneos Health, Inc. SYNH · Entity 109360 | GrantClass A Common Stock | 2,803 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-20-012777 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI (2019), L.P. · CIK 0001775519 · Director · 10% owner THOMAS H LEE PARTNERS LP · CIK 0001260945 · Director · 10% owner THL Fund VI (2019) Coinvestment Partners, L.P. · CIK 0001780726 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner THL HOLDCO, LLC · CIK 0001757181 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,028 F5 · shares: See Exhibit 99.1 for text of footnote (5). F5 · price: See Exhibit 99.1 for text of footnote (5). F6 · price: See Exhibit 99.1 for text of footnote (6). Read SEC document |
| May 24, 2019 Filed May 30, 2019 06:02 UTC | Syneos Health, Inc. SYNH · Entity 109360 | GrantClass A Common Stock | 4,122 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-19-010018 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI, L.P. · CIK 0001375668 · Director · 10% owner Thomas H. Lee Parallel (DT) Fund VI, L.P. · CIK 0001429870 · Director · 10% owner Thomas H. Lee Parallel Fund VI, L.P. · CIK 0001375663 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner ABBRECHT TODD M · CIK 0001260937 · Director THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,225 F5 · shares: See Exhibit 99.1 for text of footnote (5). F5 · price: See Exhibit 99.1 for text of footnote (5). F7 · price: See Exhibit 99.1 for text of footnote (7). Read SEC document |
| May 24, 2019 Filed May 30, 2019 06:02 UTC | Syneos Health, Inc. SYNH · Entity 109360 | GrantClass A Common Stock | 4,122 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-19-010018 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · Director · 10% owner Thomas H. Lee Equity Fund VI, L.P. · CIK 0001375668 · Director · 10% owner Thomas H. Lee Parallel (DT) Fund VI, L.P. · CIK 0001429870 · Director · 10% owner Thomas H. Lee Parallel Fund VI, L.P. · CIK 0001375663 · Director · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · Director · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · Director · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · Director · 10% owner THL Managers VI, LLC · CIK 0001604098 · Director · 10% owner ABBRECHT TODD M · CIK 0001260937 · Director THL Managers VII, LLC · CIK 0001753032 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,225 F5 · shares: See Exhibit 99.1 for text of footnote (5). F5 · price: See Exhibit 99.1 for text of footnote (5). F6 · price: See Exhibit 99.1 for text of footnote (6). Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 16:27 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 6,000,000 | $49.73 | $298,380,000.00 |
DisclosureSEC source: 0001140361-18-036238 · form4.xml · nonDerivative · entry 1 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · 10% owner Thomas H. Lee Equity Fund VI, L.P. · CIK 0001375668 · 10% owner Thomas H. Lee Parallel (DT) Fund VI, L.P. · CIK 0001429870 · 10% owner Thomas H. Lee Parallel Fund VI, L.P. · CIK 0001375663 · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · 10% owner ABBRECHT TODD M · CIK 0001260937 · Director Nelson Joshua M · CIK 0001375529 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 19,239,664 F1 · ownership.nature: See Exhibit 99.1 for text of footnote (1). F2 · ownership.nature: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). Read SEC document |
| May 24, 2018 Filed May 29, 2018 21:51 UTC | Syneos Health, Inc. SYNH · Entity 109360 | GrantClass A Common Stock | 4,103 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-026131 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · 10% owner Thomas H. Lee Equity Fund VI, L.P. · CIK 0001375668 · 10% owner Thomas H. Lee Parallel (DT) Fund VI, L.P. · CIK 0001429870 · 10% owner Thomas H. Lee Parallel Fund VI, L.P. · CIK 0001375663 · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · 10% owner ABBRECHT TODD M · CIK 0001260937 · Director Nelson Joshua M · CIK 0001375529 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,281 F4 · shares: See Exhibit 99.1 for text of footnote (4). F4 · price: See Exhibit 99.1 for text of footnote (4). F6 · price: See Exhibit 99.1 for text of footnote (6). Read SEC document |
| May 24, 2018 Filed May 29, 2018 21:51 UTC | Syneos Health, Inc. SYNH · Entity 109360 | GrantClass A Common Stock | 4,103 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-026131 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · 10% owner Thomas H. Lee Equity Fund VI, L.P. · CIK 0001375668 · 10% owner Thomas H. Lee Parallel (DT) Fund VI, L.P. · CIK 0001429870 · 10% owner Thomas H. Lee Parallel Fund VI, L.P. · CIK 0001375663 · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · 10% owner ABBRECHT TODD M · CIK 0001260937 · Director Nelson Joshua M · CIK 0001375529 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,281 F4 · shares: See Exhibit 99.1 for text of footnote (4). F4 · price: See Exhibit 99.1 for text of footnote (4). F5 · price: See Exhibit 99.1 for text of footnote (5). Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 21:20 UTC | Syneos Health, Inc. INCR · Entity 109360 | GrantClass A Common Stock | 2,178 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-030141 · form4.xml · nonDerivative · entry 3 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · 10% owner Thomas H. Lee Equity Fund VI, L.P. · CIK 0001375668 · 10% owner Thomas H. Lee Parallel (DT) Fund VI, L.P. · CIK 0001429870 · 10% owner Thomas H. Lee Parallel Fund VI, L.P. · CIK 0001375663 · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · 10% owner ABBRECHT TODD M · CIK 0001260937 · Director Nelson Joshua M · CIK 0001375529 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,178 F4 · shares: See Exhibit 99.1 for text of footnote (4). F4 · price: See Exhibit 99.1 for text of footnote (4). F6 · price: See Exhibit 99.1 for text of footnote (6). Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 21:20 UTC | Syneos Health, Inc. INCR · Entity 109360 | GrantClass A Common Stock | 2,178 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-030141 · form4.xml · nonDerivative · entry 2 THOMAS H. LEE ADVISORS, LLC · CIK 0001260943 · 10% owner Thomas H. Lee Equity Fund VI, L.P. · CIK 0001375668 · 10% owner Thomas H. Lee Parallel (DT) Fund VI, L.P. · CIK 0001429870 · 10% owner Thomas H. Lee Parallel Fund VI, L.P. · CIK 0001375663 · 10% owner Thomas H. Lee Equity Fund VII, L.P. · CIK 0001620946 · 10% owner Thomas H. Lee Parallel Fund VII, L.P. · CIK 0001620947 · 10% owner Thomas H. Lee Parallel (Cayman) Fund VII, L.P. · CIK 0001620948 · 10% owner ABBRECHT TODD M · CIK 0001260937 · Director Nelson Joshua M · CIK 0001375529 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,178 F4 · shares: See Exhibit 99.1 for text of footnote (4). F4 · price: See Exhibit 99.1 for text of footnote (4). F5 · price: See Exhibit 99.1 for text of footnote (5). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.